Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

flaxseed lignan

A group of bioactive polyphenolic phytoestrogens derived from the seed of the flax plant (Linum usitatissimum) with potential antioxidant and chemopreventive activities. Flaxseed lignan is primarily comprised of secoisolariciresinol diglucoside (SDG), isolariciresinol, matairesinol, pinoresinol and lariciresinol. SDG is converted to the enterolignans enterolactone (EL) and enterodiol (ED) by the intestinal microflora in the proximal colon. EL and ED have both weakly estrogenic and anti-estrogenic activities depending upon the tissue. The anti-estrogenic effects in reproductive tissue may help reduce the risk of hormone-associated cancers, while the estrogenic effects in bone may help maintain bone density.  Flaxseed is the richest dietary source of lignans.
Synonym:flax lignan
Search NCI's Drug Dictionary